HCW Biologics director Gary M. Winer resigns after failing to be re-elected at 2025 annual meeting

HCW Biologics Inc.

Gary M. Winer resigned from board effective June 17, 2025; seat will remain vacant.
Shareholder vote: Scott T. Garrett elected with 534,541 for; Winer had 133,365 for and 410,361 withheld.
Stockholders ratified Crowe LLP as auditor for FY 2025 (693,874 for, 595 against).
Broadridge technical glitch prevented some stockholders from virtual meeting; a quorum was present and meeting validly held.
Replay of annual meeting available at www.virtualshareholdermeeting.com/HCWB2025 through July 31, 2025.

item 5.02item 5.07item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gary M. Winer

Director

HCWB · HCW Biologics Inc.

Effective: 2025-06-17
Filed: Jun 23, 2025 23:59 UTC

On June 17, 2025, after the Annual Meeting, HCW Biologics Inc. accepted Gary M. Winer’s resignation from the Company’s Board of Directors, effective immediately.

Source: SEC EDGAR

accession 0000950170-25-089035

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.